Question

Difficulty: Very hardNephrology

Match each post-renal transplant clinical scenario and associated biopsy finding with the primary pathophysiologic mechanism responsible for the graft dysfunction.

  • A 45-year-old man, 2 months post-renal transplant, presents with a rising creatinine. Biopsy reveals dense interstitial mononuclear cell infiltrates and severe tubulitis.Direct T-lymphocyte mediated cytotoxicity against donor alloantigens
  • A 32-year-old man, 1 month post-transplant, presents with acute graft dysfunction. Biopsy reveals peritubular capillaritis, neutrophils in the microcirculation, and diffuse C4d staining.Binding of donor-specific antibodies to graft endothelium with subsequent complement cascade activation
  • A 55-year-old man, 4 years post-transplant, has slowly progressive allograft dysfunction and new-onset hypertension. Biopsy demonstrates nodular hyaline deposits in the afferent arterioles and a striped pattern of tubulointerstitial fibrosis.Chronic dose-dependent afferent arteriolar vasoconstriction leading to ischemic fibrotic damage
  • A 38-year-old woman, 6 months post-transplant, develops asymptomatic allograft dysfunction. Urinalysis demonstrates enlarged epithelial cells with irregular nuclei. Biopsy shows intranuclear inclusions in tubular epithelial cells.Reactivation of a latent polyomavirus secondary to intense pharmacological immunosuppression
  • A 29-year-old woman, 3 weeks post-transplant for end-stage renal disease, develops generalized edema and a urine protein excretion of 9 g/24 hours9 \text{ g}/24 \text{ hours}. Light microscopy of the graft is unremarkable; electron microscopy shows diffuse podocyte effacement.Direct disruption of the glomerular filtration barrier by a circulating systemic permeability factor

Answer

The correct matches correlate acute cellular rejection with T-cell cytotoxicity, antibody-mediated rejection with complement activation, calcineurin inhibitor toxicity with arteriolar vasoconstriction, BK virus nephropathy with polyomavirus reactivation, and recurrent FSGS with a circulating permeability factor.
Correct matching relies on correlating the post-transplant timeline and specific histopathologic findings with their underlying pathophysiologic mechanisms. T-cell mediated rejection is definitively identified by tubulitis; antibody-mediated rejection by C4d deposition and capillaritis; calcineurin inhibitor toxicity by arteriolar hyalinosis and striped fibrosis; BK virus by intranuclear inclusions; and recurrent FSGS by immediate heavy proteinuria and podocyte effacement in the absence of immune deposits.

Step-by-Step Solution

1
Analyze the 2-month post-transplant scenario demonstrating tubulitis.
Identified as acute cellular rejection.
Tubulitis and interstitial mononuclear infiltrates are the histopathologic hallmarks of T-cell mediated cytotoxicity.
2
Analyze the 1-month post-transplant scenario demonstrating C4d staining.
Identified as acute antibody-mediated rejection.
C4d is a degradation product of complement activation, providing definitive evidence that donor-specific antibodies are binding to the graft endothelium.
3
Analyze the 4-year post-transplant scenario demonstrating hypertension and arteriolar hyalinosis.
Identified as chronic calcineurin inhibitor toxicity.
Long-term use of tacrolimus or cyclosporine causes chronic afferent arteriolar vasoconstriction, leading to ischemic striped fibrosis.
4
Analyze the 6-month post-transplant scenario demonstrating decoy cells and intranuclear inclusions.
Identified as BK virus nephropathy.
Pharmacological immunosuppression allows reactivation of latent polyomavirus, which directly infects tubular epithelial cells.
5
Analyze the 3-week post-transplant scenario demonstrating nephrotic-range proteinuria and isolated podocyte effacement.
Identified as recurrent primary FSGS.
Immediate massive proteinuria post-transplant for end-stage renal disease without light microscopic immune complex deposition strongly suggests a circulating permeability factor.

Key Concept

Pathophysiology and histopathologic differentiation of renal allograft dysfunction
Rate this question